1. Biotech IPO bonanza: Legend Biotech, Forma Therapeutics, Repare — COVID-19 could slow progress in reducing cancer death, NCI warns — ASCO 2020 news from Merck, AstraZeneca, Pfizer, more — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

For Sale

Discussion in 'Genoptix' started by anonymous, May 25, 2016 at 8:43 AM.

  1. anonymous

    anonymous Guest

    How soon before you are Genoptix a Lab Corp company?
     
  2. anonymous

    anonymous Guest

    LabCorp will not buy Genoptix. The paid 923 million for Genzyne and dropped the value to 250 million in 3 years. Novartis may continue the blood letting to use the technology for drug discovery. The Genies need to find a new bottle.